Chemicals & Small Molecules

Subtilisin (EC 3. 4. 21. 14) is a bacterially derived serine protease that promotes hepatic LDL receptor (LDLR) degradation and can be used in the study of cardiovascular disease.

Phytohemagglutinin P (PHA-P) is a mitogen that selectively stimulates hematogenous or lymphoid monocytic cells [1].

Lavandoside is a compound derived from Helianthemum ruficomum with antioxidant activity.

M826, a non-peptide, potent, selective, and reversible caspase-3 inhibitor, exhibits an IC50 of 0.005 μM and demonstrates strong anti-apoptotic activity in vitro and in vivo animal models. It is useful for research into nervous system diseases [1].

PIK5-12d is a PROTAC PIKfyve degrader with antitumor activity that induces massive cytoplasmic vacuolization and blocks autophagic flow. PIK5-12d inhibits the value-added of cancer cells and can be used in the study of prostate cancer.

MLKL-IN-6 (compound P28) is a mixed lineage kinase inhibitor that specifically targets the Mixed Lineage Kinase domain-like (MLKL) protein. It effectively prevents MLKL phosphorylation and oligomerization, which are critical steps in cell necrosis. Additionally, MLKL-IN-6 restrains immune cell death, diminishes adhesion factor expression, exhibits low cytotoxicity, impedes hepatic stellate cell activation, decreases liver fibrosis marker levels, and exerts anti-fibrotic effects [1].

VU6004909 is a potent mGlu5 receptor orthosteric modulator (EC50:25.7nM) that reverses MK801-induced cortical activity enhancement and cognitive dysfunction, and can be used in the study of neurological disorders.

Compound 142 (also known as Compound 235) is a PTPN inhibitor with potential applications in cancer research [1].

Anticancer Agent 143 (Compound 369), a potent dual inhibitor targeting PTPN2 and PTP1B, exhibits IC50 values below 2.5 nM. It is employed in cancer research [1].